The bigger picture of FTO - The first GWAS-identified obesity gene

Nature Reviews Endocrinology

Volumn 10, Issue 1, 2014, Pages 51-61

  Loos, Ruth J F ^a   Yeo, Giles S H ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 N METHYLADENOSINE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1;

BODY WEIGHT; COMORBIDITY; ENERGY; FOOD INTAKE; FTO GENE; GENE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; LIFESTYLE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RPGPIP1L GENE; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT CONTROL;

ALLELES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK FACTORS;

EID: 85047688293     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.227     Document Type: Review

References (188)

1. Elks, C. E. et al. Variability in the heritability of body mass index: A systematic review and meta-regression. Front. Endocrinol. (Lausanne) 3, 29 (2012).
2. Maes, H. H., Neale, M. C. & Eaves, L. J. Genetic and environmental factors in relative body weight and human obesity. Behav. Genet. 27, 325-351 (1997).
3. Loos, R. J. F. in Adipose Tissue Biology (ed. Symonds, M. E.) 317-378 (Springer, 2012).
4. Hindorff, L. A. et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA 106, 9362-9367 (2009).
5. Hindorff, L. A., MacArthur, J., Morales, J., Junkins, H. A., Hall, P. N., Klemm, A. K. & Manolio, T. A. A catalog of published genome-wide association studies [online], http://www.genome.gov/gwastudies (2013).
6. Day, F. R. & Loos, R. J. Developments in obesity genetics in the era of genome-wide association studies. J. Nutrigenet. Nutrigenomics 4, 222-238 (2011).
7. Lu, Y. & Loos, R. J. Obesity genomics: Assessing the transferability of susceptibility loci across diverse populations. Genome Med. 5, 55 (2013).
8. Frayling, T. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894 (2007).
9. Scuteri, A. et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 3, e115 (2007).
10. Dina, C. et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 39, 724-726 (2007).
11. Loos, R. J. et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat. Genet. 40, 768-775 (2008).
12. Willer, C. J. et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 41, 25-34 (2009).
13. Thorleifsson, G. et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 41, 18-24 (2009).
14. Lindgren, C. M. et al. Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. PLoS Genet. 5, e1000508 (2009).
15. Heard-Costa, N. L. et al. NRXN3 is a novel locus for waist circumference: A genome-wide association study from the CHARGE Consortium. PLoS Genet. 5, e1000539 (2009).
16. Speliotes, E. K. et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937-948 (2010).
17. Kilpelainen, T. O. et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat. Genet. 43, 753-760 (2011).
18. Berndt, S. I. et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat. Genet. 45, 501-512 (2013).
19. Meyre, D. et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat. Genet. 41, 157-159 (2009).
20. Scherag, A. et al. Two new loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and German study groups. PLoS Genet. 6, e1000916 (2010).
21. Bradfield, J. P. et al. A genome-wide association meta-analysis identifies new childhood obesity loci. Nat. Genet. 44, 526-531 (2012).
22. Wheeler, E. et al. Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity. Nat. Genet. 45, 513-517 (2013).
23. Cho, Y. S. et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat. Genet. 41, 527-534 (2009).
24. Wen, W. et al. Meta-analysis identifies common variants associated with body mass index in east Asians. Nat. Genet. 44, 307-311 (2012).
25. Okada, Y. et al. Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations. Nat. Genet. 44, 302-306 (2012).
26. Monda, K. L. et al. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat. Genet. 45, 690-696 (2013).
27. Peters, U. et al. A systematic mapping approach of 16q12.2/FTO and BMI in more than 20,000 African Americans narrows in on the underlying functional variation: Results from the Population Architecture using Genomics and Epidemiology (PAGE) study. PLoS Genet. 9, e1003171 (2013).
28. Stratigopoulos, G. et al. Regulation of Fto/Ftm gene expression in mice and humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1185-R1196 (2008).
29. Stratigopoulos, G., LeDuc, C. A., Cremona, M. L., Chung, W. K. & Leibel, R. L. Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein1like (RPGRIP1L) genes and coordinates leptin receptor signaling. J. Biol. Chem. 286, 2155-2170 (2011).
30. Li, S. et al. Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies. Am. J. Clin. Nutr. 91, 184-190 (2010).
31. Tan, J. T. et al. FTO variants are associated with obesity in the Chinese and Malay populations in Singapore. Diabetes 57, 2851-2857 (2008).
32. Liu, Y. et al. Meta-analysis added power to identify variants in FTO associated with type 2 diabetes and obesity in the Asian population. Obesity 18, 1619-1624 (2010).
33. Ng, M. C. Y. et al. Implication of genetic variants near NEGR1, SEC16B, TMEM18, ETV5/DGKG, GNPDA2, LIN17C/BDNF, MTCH2, BCDIN3D/FAIM2, SH2B1, FTO, MC4R, AND KCTD15 with obesity and type 2 diabetes in 7,705 Chinese. J. Clin. Endocrinol. Metab. 95, 2418-2425 (2010).
34. Chang, Y. C. et al. Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population. Diabetes 57, 2245-2252 (2008).
35. Shi, J. et al. Evaluation of genetic susceptibility loci for obesity in Chinese women. Am. J. Epidemiol. 172, 244-254 (2010).
36. Sun, Y., Sun, J., Wang, X., You, W. & Yang, M. Variants in the fat mass and obesity associated (FTO) gene are associated with obesity and Creactive protein levels in Chinese Han populations. Clin. Invest. Med. 33, E405-E412 (2010).
37. Wang, J. et al. Study of eight GWAS-identified common variants for association with obesity-related indices in Chinese children at puberty. Int. J. Obes. (Lond.) 36, 542-547 (2012).
38. Wu, L. et al. Associations of six single nucleotide polymorphisms in obesity-related genes with BMI and risk of obesity in Chinese children. Diabetes 59, 3085-3089 (2010).
39. Xi, B. et al. Associations of obesity susceptibility loci with hypertension in Chinese children. Int. J. Obes. (Lond.) 37, 926-930 (2013).
40. Hotta, K. et al. Variations in the FTO gene are associated with severe obesity in the Japanese. J. Hum. Genet. 53, 546-553 (2008).
41. Omori, S. et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 57, 791-795 (2008).
42. Tabara, Y. et al. Prognostic significance of FTO genotype in the development of obesity in Japanese: The JSHIPP study. Int. J. Obes. 33, 1243-1248 (2009).
43. Karasawa, S. et al. Association of the common fat mass and obesity associated (FTO) gene polymorphism with obesity in a Japanese population. Endocr. J. 57, 293-301 (2010).
44. Takeuchi, F. et al. Association of genetic variants for susceptibility to obesity with type 2 diabetes in Japanese individuals. Diabetologia 54, 1350-1359 (2011).
45. Cha, S. W. et al. Replication of genetic effects of FTO polymorphisms on BMI in a Korean population. Obesity (Silver Spring) 16, 2187-2189 (2008).
46. Hong, K. W. & Oh, B. Recapitulation of genome-wide association studies on body mass index in the Korean population. Int. J. Obes. (Lond.) 36, 1127-1130 (2012).
47. Binh, T. Q. et al. Association of the common FTO-rs9939609 polymorphism with type 2 diabetes, independent of obesity-related traits in a Vietnamese population. Gene 513, 31-35 (2013).
48. Croteau-Chonka, D. C. et al. Genome-wide association study of anthropometric traits and evidence of interactions with age and study year in Filipino women. Obesity (Silver Spring) 19, 1019-1027 (2010).
49. Yajnik, C. et al. FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians. Diabetologia 52, 247-252 (2009).
50. Ramya, K., Radha, V., Ghosh, S., Majumder, P. P. & Mohan, V. Genetic variations in the FTO gene are associated with type 2 diabetes and obesity in south Indians (CURES79). Diabetes Technol. Ther. 13, 33-42 (2011).
51. Taylor, A. E. et al. Associations of FTO and MC4R variants with obesity traits in indians and the role of rural/urban environment as a possible effect modifier. J. Obes. 2011, 307542 (2011).
52. Chauhan, G. et al. Common variants of FTO and the risk of obesity and type 2 diabetes in Indians. J. Hum. Genet. 56, 720-726 (2011).
53. Vasan, S. K. et al. Associations of variants in FTO and near MC4R with obesity traits in South Asian Indians. Obesity (Silver Spring) 20, 2268-2277 (2012).
54. Sanghera, D. et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF12BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med. Genet. 9, 59 (2008).
55. Moore, S. C. et al. Common genetic variants and central adiposity among Asian-Indians. Obesity (Silver Spring) 20, 1902-1908 (2012).
56. Dwivedi, O. P. et al. Common variants of FTO are associated with childhood obesity in a cross-sectional study of 3,126 urban Indian children. PLoS ONE 7, e47772 (2012).
57. Rees, S. D. et al. An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference. Diabet. Med. 28, 673-680 (2011).
58. Li, H. et al. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 55, 981-995 (2012).
59. Grant, S. F. et al. Association analysis of the FTO gene with obesity in children of Caucasian and African ancestry reveals a common tagging SNP. PLoS ONE 3, e1746 (2008).
60. Liu, G. et al. FTO variant rs9939609 is associated with body mass index and waist circumference, but not with energy intake or physical activity in European-and African-American youth. BMC Med. Genet. 11, 57 (2010).
61. Graff, M. et al. Estimation of genetic effects on BMI during adolescence in an ethnically diverse cohort: The National Longitudinal Study of Adolescent Health. Nutr. Diabetes 2, e47 (2012).
62. Adeyemo, A. et al. FTO genetic variation and association with obesity in west africans and african americans. Diabetes 59, 1549-1554 (2010).
63. Hennig, B. et al. FTO gene variation and measures of body mass in an African population. BMC Med. Genet. 10, 21 (2009).
64. Hassanein, M. T. et al. Fine mapping of the association with obesity at the FTO locus in African-derived populations. Hum. Mol. Genet. 19, 2907-2916 (2010).
65. Bressler, J., Kao, W. H., Pankow, J. S. & Boerwinkle, E. Risk of type 2 diabetes and obesity is differentially associated with variation in fto in whites and african-americans in the ARIC Study. PLoS ONE 5, e10521 (2010).
66. Avery, C. L. et al. A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains. PLoS Genet. 7, e1002322 (2011).
67. Cauchi, S. et al. European genetic variants associated with type 2 diabetes in North African Arabs. Diabetes Metab. 38, 316-323 (2012).
68. Hallman, D. M. et al. The association of variants in the FTO gene with longitudinal body mass index profiles in non-Hispanic white children and adolescents. Int. J. Obes (Lond.) 36, 61-68 (2012).
69. Lombard, Z. et al. Appetite regulation genes are associated with body mass index in black South African adolescents: A genetic association study. BMJ Open 2, e000873 (2012).
70. Hester, J. M. et al. Implication of European-derived adiposity loci in African Americans. Int. J. Obes. (Lond.) 36, 465-473 (2012).
71. Ng, M. C. et al. Genome-wide association of BMI in African Americans. Obesity (Silver Spring) 20, 622-627 (2012).
72. Fesinmeyer, M. D. et al. Effects of smoking on the genetic risk of obesity: The population architecture using genomics and epidemiology study. BMC Med. Genet. 14, 6 (2013).
73. Demerath, E. W. et al. Interaction of FTO and physical activity level on adiposity in African-American and European-American adults: The ARIC study. Obesity (Silver Spring) 19, 1866-1872 (2011).
74. Wing, M. R. et al. Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study. Hum. Genet. 125, 615-626 (2009).
75. Villalobos-Comparan, M. et al. The FTO gene is associated with adulthood obesity in the Mexican population. Obesity (Silver Spring) 16, 2296-2301 (2008).
76. Dong, C. et al. Genome-wide linkage and peak-wide association study of obesity-related quantitative traits in Caribbean Hispanics. Hum. Genet. 129, 209-219 (2011).
77. Song, Y. et al. FTO polymorphisms are associated with obesity but not diabetes risk in postmenopausal women. Obesity (Silver Spring) 16, 2472-2480 (2008).
78. Rong, R. et al. Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF32BP2, LOC387761 and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes 58, 478-488 (2009).
79. Haworth, C. M. A. et al. Increasing heritability of BMI and stronger associations with the FTO Gene over childhood. Obesity 16, 2663-2668 (2008).
80. Cecil, J. E., Tavendale, R., Watt, P., Hetherington, M. M. & Palmer, C. N. A. An obesity-associated fto gene variant and increased energy intake in children. N. Engl. J. Med. 359, 2558-2566 (2008).
81. Zhao, J. et al. Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI. Diabetes 59, 751-755 (2010).
82. Melen, E. et al. Genome-wide association study of body mass index in 23,000 individuals with and without asthma. Clin. Exp. Allergy 43, 463-474 (2013).
83. den Hoed, M. et al. Genetic susceptibility to obesity and related traits in childhood and adolescence. Diabetes 59, 2980-2988 (2010).
84. Lauria, F. et al. Prospective analysis of the association of a common variant of FTO (rs9939609) with adiposity in children: Results of the IDEFICS study. PLoS ONE 7, e48876 (2012).
85. Zhao, J. et al. Role of BMI-associated loci identified in GWAS meta-analyses in the context of common childhood obesity in European Americans. Obesity (Silver Spring) 19, 2436-2439 (2011).
86. Graff, M. et al. Genome-wide analysis of BMI in adolescents and young adults reveals additional insight into the effects of genetic loci over the life course. Hum. Mol. Genet. 22, 3597-3607 (2013).
87. Hardy, R. et al. Life course variations in the associations between FTO and MC4R gene variants and body size. Hum. Mol. Genet. 19, 545-552 (2010).
88. Rzehak, P. et al. Associations between BMI and the FTO gene are age dependent: Results from the GINI and LISA birth cohort studies up to age 6 years. Obes. Facts 3, 180 (2010).
89. Cauchi, S. et al. Combined effects of MC4R and FTO common genetic variants on obesity in European general populations. J. Mol. Med. 87, 537-546 (2009).
90. Jess, T. et al. Impact on weight dynamics and general growth of the common FTO rs9939609: A longitudinal Danish cohort study. Int. J. Obes 32, 1388-1394 (2008).
91. Kilpelainen, T. O. et al. Obesity-susceptibility loci have a limited influence on birth weight: A meta-analysis of up to 28,219 individuals. Am. J. Clin. Nutr. 93, 851-860 (2011).
92. Horikoshi, M. et al. New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat. Genet. 45, 76-82 (2013).
93. Qi, L. et al. Fat mass-and obesity-associated (FTO) gene variant is associated with obesity: Longitudinal analyses in two cohort studies and functional test. Diabetes 57, 3145-3151 (2008).
94. Sovio, U. et al. Association between common variation at the FTO locus and changes in body mass index from infancy to late childhood: The complex nature of genetic association through growth and development. PLoS Genet. 7, e1001307 (2011).
95. Speakman, J. R., Rance, K. A. & Johnstone, A. M. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity 16, 1961-1965 (2008).
96. Timpson, N. J. et al. The fat mass-and obesity-associated locus and dietary intake in children. Am. J. Clin. Nutr. 88, 971-978 (2008).
97. Sonestedt, E. et al. Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. Am. J. Clin. Nutr. 90, 1418-1425 (2009).
98. Lee, H. J. et al. Effects of common FTO gene variants associated with BMI on dietary intake and physical activity in Koreans. Clin. Chim. Acta 411, 1716-1722 (2010).
99. Park, S. L. et al. Association of the FTO obesity risk variant rs8050136 with percentage of energy intake from fat in multiple racial/ethnic populations: The PAGE Study. Am. J. Epidemiol. 178, 780-790 (2013).
100. Ahmad, T. et al. Lifestyle interaction with fat mass and obesity-associated (FTO) genotype and risk of obesity in apparently healthy, U. S. women. Diabetes Care 34, 675-680 (2011).
101. Wardle, J. et al. Obesity associated genetic variation in FTO is associated with diminished satiety. J. Clin. Endocr. Metab. 93, 3640-3643 (2008).
102. Wardle, J., Llewellyn, C., Sanderson, S. & Plomin, R. The FTO gene and measured food intake in children. Int. J. Obes 33, 42-45 (2008).
103. McCaffery, J. M. et al. Obesity susceptibility loci and dietary intake in the Look AHEAD Trial. Am. J. Clin. Nutr. 95, 1477-1486 (2012).
104. Brunkwall, L. et al. Genetic variation in the fat mass and obesity-associated gene (FTO) in association with food preferences in healthy adults. Food Nutr. Res. 57, 20028 (2013).
105. Tanofsky-Kraff, M. et al. The FTO gene rs9939609 obesity-risk allele and loss of control over eating. Am. J. Clin. Nutr. 90, 1483-1488 (2009).
106. Tanaka, T. et al. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. Am. J. Clin. Nutr. 97, 1395-1402 (2013).
107. Bauer, F. et al. Obesity genes identified in genome-wide association studies are associated with adiposity measures and potentially with nutrient-specific food preference. Am. J. Clin. Nutr. 90, 951-959 (2009).
108. Corella, D. et al. A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI. J. Nutr. 141, 2219-2225 (2011).
109. Hubacek, J. A., Pikhart, H., Peasey, A., Kubinova, R. & Bobak, M. FTO variant, energy intake, physical activity and basal metabolic rate in Caucasians. The HAPIEE study. Physiol. Res. 60, 175-183 (2010).
110. Holzapfel, C. et al. Genes and lifestyle factors in obesity: Results from 12,462 subjects from MONICA/KORA. Int. J. Obes. 34, 1538-1545 (2010).
111. Franks, P. W. et al. Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia 51, 2214-2223 (2008).
112. Rampersaud, E. et al. Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch. Intern. Med. 168, 1791-1797 (2008).
113. Ahmad, T. et al. The Fat-Mass and Obesity-Associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. Am. Heart J. 160, 1163-1169 (2010).
114. Vimaleswaran, K. S. et al. Physical activity attenuates the body mass index increasing influence of genetic variation in the FTO gene. Am. J. Clin. Nutr. 90, 425-428 (2009).
115. Kilpelainen, T. O. Physical activity attenuates the influence of FTO variants on obesity risk; a meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 8, e1001116 (2011).
116. Andreasen, C. H. et al. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 57, 264-268 (2008).
117. Sonestedt, E. et al. Association between fat intake, physical activity and mortality depending on genetic variation in FTO. Int. J. Obes (Lond.) 35, 1041-1049 (2010).
118. Bell, C. G. et al. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS ONE 5, e14040 (2010).
119. Toperoff, G. et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum. Mol. Genet. 21, 371-383 (2012).
120. Almen, M. S. et al. Genome wide analysis reveals association of a FTO gene variant with epigenetic changes. Genomics 99, 132-137 (2012).
121. Heid, I. M. et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42, 949-960 (2010).
122. Fox, C. S. et al. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLoS Genet. 8, e1002695 (2012).
123. Fall, T. et al. The role of adiposity in cardiometabolic traits: A mendelian randomization analysis. PLoS Med. 10, e1001474 (2013).
124. Hertel, J. K. et al. FTO, type 2 diabetes, and weight gain throughout adult life: A meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes 60, 1637-1644 (2011).
125. Brennan, P. et al. Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int. J. Epidemiol. 38, 971-975 (2009).
126. Delahanty, R. J. et al. Association of obesity-related genetic variants with endometrial cancer risk: A report from the Shanghai Endometrial Cancer Genetics Study. Am. J. Epidemiol. 174, 1115-1126 (2011).
127. Machiela, M. J. et al. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium. Am. J. Epidemiol. 176, 1121-1129 (2012).
128. Lurie, G. et al. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS ONE 6, e16756 (2011).
129. Long, J. et al. Evaluating genome-wide association study-identified breast cancer risk variants in African-American women. PLoS ONE 8, e58350 (2013).
130. Pierce, B. L., Austin, M. A. & Ahsan, H. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: An analysis of PanScanI data. Cancer Causes Control 22, 877-83 (2011).
131. Lewis, S. J. et al. Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk. PLoS ONE 5, e13485 (2010).
132. Gaudet, M. M. et al. No association between FTO or HHEX and endometrial cancer risk. Cancer Epidemiol. Biomarkers Prev. 19, 2106-2109 (2010).
133. Lim, U. et al. Susceptibility variants for obesity and colorectal cancer risk: The multiethnic cohort and PAGE studies. Int. J. Cancer 131, E1038-E1043 (2012).
134. Li, G., Chen, Q., Wang, L., Ke, D. & Yuan, Z. Association between FTO gene polymorphism and cancer risk: Evidence from 16,277 cases and 31,153 controls. Tumour Biol. 33, 1237-1243 (2012).
135. Zheng, W. et al. Common genetic determinants of breast-cancer risk in East Asian women: A collaborative study of 23,637 breast cancer cases and 25,579 controls. Hum. Mol. Genet. 22, 2539-2550 (2013).
136. Garcia-Closas, M. et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat. Genet. 45, 392-398 (2013).
137. Iles, M. M. et al. A variant in FTO shows association with melanoma risk not due to BMI. Nat. Genet. 45, 428-432 (2013).
138. Meyre, D. et al. Prevalence of lossoffunction FTO mutations in lean and obese individuals. Diabetes 59, 311-318 (2010).
139. Deliard, S. et al. The missense variation landscape of FTO, MC4R, and TMEM18 in obese children of African Ancestry. Obesity (Silver Spring) 21, 159-63 (2013).
140. Zheng, Z. et al. Screening for Coding Variants in FTO and SH2B1 Genes in Chinese Patients with Obesity. PLoS ONE 8, e67039 (2013).
141. Gerken, T. et al. The obesity-associated FTO gene encodes a 2oxoglutaratedependent nucleic acid demethylase. Science 318, 1469-1472 (2007).
142. Jia, G. et al. Oxidative demethylation of 3methylthymine and 3methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett. 582, 3313-3319 (2008).
143. Jia, G. et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885-887 (2011).
144. Han, Z. et al. Crystal structure of the FTO protein reveals basis for its substrate specificity. Nature 464, 1205-1209 (2010).
145. Desrosiers, R., Friderici, K. & Rottman, F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc. Natl Acad. Sci. USA 71, 3971-3975 (1974).
146. Kowalak, J. A., Pomerantz, S. C., Crain, P. F. & McCloskey, J. A. A novel method for the determination of post-transcriptional modification in RNA by mass spectrometry. Nucleic Acids Res. 21, 4577-4585 (1993).
147. Chambers, J. C. et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat. Genet. 40, 716-718 (2008).
148. Vaisse, C., Clement, K., Guy-Grand, B. & Froguel, P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20, 113-114 (1998).
149. Yeo, G. S. et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20, 111-112 (1998).
150. Challis, B. G. et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum. Mol. Genet. 11, 1997-2004 (2002).
151. Krude, H. et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155-157 (1998).
152. Gray, J. et al. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55, 3366-3371 (2006).
153. Benzinou, M. et al. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat. Genet. 40, 943-945 (2008).
154. Jackson, R. S. et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16, 303-306 (1997).
155. Peters, T., Ausmeier, K. & Ruther, U. Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation. Mamm. Genome 10, 983-986 (1999).
156. Anselme, I., Laclef, C., Lanaud, M., Ruther, U. & Schneider-Maunoury, S. Defects in brain patterning and head morphogenesis in the mouse mutant Fused toes. Dev. Biol. 304, 208-220 (2007).
157. van der Hoeven, F. et al. Programmed cell death is affected in the novel mouse mutant Fused toes (Ft). Development 120, 2601-2607 (1994).
158. Fischer, J. et al. Inactivation of the Fto gene protects from obesity. Nature 458, 894-898 (2009).
159. McMurray, F. et al. Adult onset global loss of the fto gene alters body composition and metabolism in the mouse. PLoS Genet. 9, e1003166 (2013).
160. Boissel, S. et al. Lossoffunction mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am. J. Hum. Genet. 85, 106-111 (2009).
161. Delous, M. et al. The ciliary gene RPGRIP1L is mutated in cerebellooculorenal syndrome (Joubert syndrome type B) and Meckel syndrome. Nat. Genet. 39, 875-881 (2007).
162. Wu, Q., Saunders, R. A., Szkudlarek-Mikho, M., Serna Ide, L. & Chin, K. V. The obesity-associated Fto gene is a transcriptional coactivator. Biochem. Biophys. Res. Commun. 401, 390-395 (2010).
163. Church, C. et al. Overexpression of Fto leads to increased food intake and results in obesity. Nat. Genet. 42, 1086-1092 (2010).
164. Tung, Y. C. et al. Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS ONE 5, e8771 (2010).
165. Gao, X. et al. The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice. PLoS ONE 5, e14005 (2010).
166. Ma, M., Harding, H. P., O'Rahilly, S., Ron, D. & Yeo, G. S. Kinetic analysis of FTO (fat mass and obesity-associated) reveals that it is unlikely to function as a sensor for 2oxoglutarate. Biochem. J. 444, 183-187 (2012).
167. Cheung, M. K., Gulati, P., O'Rahilly, S. & Yeo, G. S. FTO expression is regulated by availability of essential amino acids. Int. J. Obes (Lond.) 37, 744-747 (2013).
168. Gulati, P. et al. Role for the obesity-related FTO gene in the cellular sensing of amino acids. Proc. Natl Acad. Sci. USA 110, 2557-2562 (2013).
169. Quevillon, S., Robinson, J. C., Berthonneau, E., Siatecka, M. & Mirande, M. Macromolecular assemblage of aminoacyl-tRNA synthetases: Identification of protein-protein interactions and characterization of a core protein. J. Mol. Biol. 285, 183-195 (1999).
170. Dominissini, D. et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201-206 (2012).
171. Meyer, K. D. et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell 149, 1635-1646 (2012).
172. Bokar, J. A., Shambaugh, M. E., Polayes, D., Matera, A. G. & Rottman, F. M. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA 3, 1233-1247 (1997).
173. Zheng, G. et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49, 18-29 (2013).
174. Hess, M. E. et al. The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat. Neurosci. 16, 1042-1048 (2013).
175. Karra, E. et al. A link between FTO, ghrelin, and impaired brain food-cue responsivity. J. Clin. Invest. 123, 3539-3551 (2013).
176. Abecasis, G. R. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65 (2012).
177. Freathy, R. M. et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected, given its effect on BMI. Diabetes 57, 1419-1426 (2008).
178. Asselbergs, F. W. et al. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am. J. Hum. Genet. 91, 823-838 (2012).
179. RobiouPont, S. et al. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population. Int. J. Obes. (Lond.) 37, 980-985 (2013).
180. Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981-990 (2012).
181. Hubacek, J. A. et al. The FTO gene polymorphism is associated with end-stage renal disease: Two large independent case-control studies in a general population. Nephrol. Dial. Transplant. 27, 1030-1035 (2012).
182. Franceschini, N. et al. The association of genetic variants of type 2 diabetes with kidney function. Kidney Int. 82, 220-225 (2012).
183. Timpson, N. J. et al. Does greater adiposity increase blood pressure and hypertension risk: Mendelian randomization using the FTO/MC4R genotype. Hypertension 54, 84-90 (2009).
184. Elks, C. E. et al. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat. Genet. 42, 1077-1085 (2010).
185. Zeggini, E. et al. Identification of new susceptibility loci for osteoarthritis (arcOGEN): A genome-wide association study. Lancet 380, 815-823 (2012).
186. Panoutsopoulou, K. et al. The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: A mendelian randomisation study. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis- 2013-203772.
187. Samaan, Z. et al. The protective effect of the obesity-associated rs9939609 A variant in fat mass-and obesity-associated gene on depression. Mol. Psychiatry http://dx.doi.org/10.1038/mp.2012-178.
188. Bressler, J. et al. Fat mass and obesity gene and cognitive decline: The Atherosclerosis Risk in Communities Study. Neurology 80, 92-99 (2013).